Hadassah

Spotlight on Hadassah’s Dr. Yael Houri-Haddad: Specialist in Oral Biology

Monday, Nov 14 2011

Dr. Yael Houri-Haddad, who immigrated to Israel from Tunisia at age 14, is a Hadassah University Medical Center dentist with a PhD in oral biology. She acquired both specialties at Hadassah where she now teaches, treats patients, and conducts research in the Department of Prosthodontics at the Hadassah Hebrew University School of Dental Medicine.

Dr. Houri-Haddad spent her sabbatical year at Boston University's School of Dental Medicine doing research on the control of inflammatory gum disease. Funded by an Israel Science Foundation grant, she devoted the following year to exploring the disease's genetic component at the Forsyth Institute, a Harvard affiliate. Now that she has returned home, her studies in Boston will augment her research on the genetic basis of gum disease.

Long before she arrived in Israel, Dr. Houri-Haddad relates, she was already familiar with Hadassah because "my mother used to travel from Tunisia to Hadassah for treatment." Dr. Houri-Haddad began her "Hadassah life" with National Service in the Department of Orthopedics. She was then accepted by both the Medical School and the Dental School, chose dentistry, and has been part of Hadassah ever since. As she expresses, "This is my country, this is my home. Hadassah is my home."

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Aug 16 2017

Gazan Boy Walks for First Time at Hadassah

Unable to stand on his feet, suffering from severe respiratory distress, a four-year-old boy from Gaza gained the ability to walk once Hadassah Hospital surgeons identified and removed a large tumor lodged in his chest.

READ MORE ›
alt_text

Wednesday, Aug 16 2017

Hadassah Hosts Health Innovation Conference

Over one hundred doctors, researchers, and entrepreneurs gathered at Hadassah Hospital Ein Kerem this summer to discuss how to advance the quality of patient care with computational power.

READ MORE ›
alt_text

Monday, Aug 14 2017

Hadassah Hosts First Human Trial with Drug to Fight Nasty Bacterial Infection

Immuron, an Australian biopharmaceutical company, has received approval from the Hadassah Medical Organization’s ethics committee and Israel’s Ministry of Health to begin its first clinical trial with a new drug to fight a bacterial infection called Clostridium Difficile (CDI).

READ MORE ›
alt_text

Thursday, Aug 3 2017

Mystery of Devastating Pediatric Disease Solved by Hadassah Team

A genetic mutation causing a rare and devastating pediatric neurological disease that has puzzled medical centers around the world has been identified at the Hadassah Medical Organization by Prof. Orly Elpeleg, head of Hadassah's Department of Genetics and Metabolic Diseases.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More